Single-administration vaccines: controlled-release technology to mimic repeated immunizations

被引:106
作者
Cleland, JL [1 ]
机构
[1] Genentech Inc, Pharmaceut R&D, San Francisco, CA 94080 USA
关键词
D O I
10.1016/S0167-7799(98)01272-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The most effective mechanism for the elimination of disease from society is the use of vaccinations, but these often require repeated administration. However, single-administration vaccine formulations provide the repeated administrations automatically. One approach is the development of injectable controlled-release microsphere formulations containing the vaccine antigen that is released as a pulse 1-6 months after injection. The time of the pulse is dependent upon the rate of polymer degradation, which is dictated by the polymer's composition and molecular weight. This controlled-release technology may provide complete protection against disease after a single administration.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 33 条
[1]   SUBCUTICULAR SUTURES AND THE RATE OF INFLAMMATION IN NONCONTAMINATED WOUNDS [J].
AUSTIN, PE ;
DUNN, KA ;
EILYCOFIELD, K ;
BROWN, CK ;
WOODEN, WA ;
BRADFIELD, JF .
ANNALS OF EMERGENCY MEDICINE, 1995, 25 (03) :328-330
[2]   Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method [J].
BlancoPrieto, MJ ;
Leo, E ;
Delie, F ;
Gulik, A ;
Couvreur, P ;
Fattal, E .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1127-1129
[3]   TREATMENT OF CENTRAL PRECOCIOUS PUBERTY WITH DEPOT LEUPRORELIN [J].
CAREL, JC ;
LAHLOU, N ;
GUAZZAROTTI, L ;
JOUBERTCOLLIN, M ;
ROGER, M ;
COLLE, M ;
BERLIER, P ;
CABROL, S ;
CHATELAIN, P ;
DESPERT, F ;
MALLET, E ;
SIMONSOSKIN, S ;
SULTAN, C ;
STUCKENS, C .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (06) :699-704
[4]   Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen [J].
Chang, AC ;
Gupta, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :129-132
[5]   Genetic immunization: a new era in vaccines and immune therapeutics [J].
Chattergoon, M ;
Boyer, J ;
Weiner, DB .
FASEB JOURNAL, 1997, 11 (10) :753-763
[6]  
Cleland J L, 1997, Pharm Biotechnol, V10, P1
[7]   Development of a single-shot subunit vaccine for HIV-1 .2. Defining optimal autoboost characteristics to maximize the humoral immune response [J].
Cleland, JL ;
Barron, L ;
Berman, PW ;
Daugherty, A ;
Gregory, T ;
Lim, A ;
Vennari, J ;
Wrin, T ;
Powell, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1346-1349
[8]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475
[9]   Development of a single-shot subunit vaccine for HIV-1 .4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres [J].
Cleland, JL ;
Lim, A ;
Barron, L ;
Duenas, ET ;
Powell, MF .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (02) :135-150
[10]  
CLELAND JL, 1997, INT S CONTROL REL BI, V24, P893